Survival from Stomach Cancer in England and Wales
Author Information
Author(s): S Rao, D Cunningham
Primary Institution: Royal Marsden Hospital
Conclusion
There has been a consistent rise in 1-year survival of gastric cancer, reflecting improved treatment and management practices.
Supporting Evidence
- Perioperative chemotherapy has shown improved survival rates compared to surgery alone.
- Staging techniques have improved, leading to better patient outcomes.
- Chemotherapy for advanced gastric cancer has produced a modest survival advantage.
Takeaway
Doctors have found better ways to treat stomach cancer, which helps more people survive longer.
Methodology
The study evaluated treatment outcomes and survival rates of gastric cancer patients over time, including the impact of chemotherapy and surgical practices.
Potential Biases
There may be biases related to patient selection and referral patterns to specialist centers.
Limitations
The study may not account for all variables affecting survival rates, such as socioeconomic factors.
Participant Demographics
The study included patients with gastric cancer in England and Wales, with noted disparities in survival based on socioeconomic status.
Statistical Information
P-Value
0.002
Confidence Interval
95% CI: 0.56–0.88
Statistical Significance
p=0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website